Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Multi-center Study of the Efficacy and Safety of MCC in the Treatment of Patients With Non-muscle Invasive (Superficial) Bladder Cancer at High Risk of Progression and Who Are Refractory to BCG

NCT00406068 is registered in ClinicalTrials.gov with Bioniche Life Sciences Inc. as lead sponsor.

NCT NCT00406068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00406068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Multi-center Study of the Efficacy and Safety of MCC in the Treatment of Patients With Non-muscle Invasive (Superficial) Bladder Cancer at High Risk of Progression and Who Are Refractory to BCG
Lead sponsor
Bioniche Life Sciences Inc.
Phase
Phase 2/3
Overall status
Completed
Start date
November 30, 2006
Completion date
July 31, 2011
Enrollment
129 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

bladder neoplasms